• Explore /
  • Poster
  • / Personalized antibodies for gastroesophageal adenocarcinoma (PANGEA): A phase II precision medicine trial (NCT02213289).

Personalized antibodies for gastroesophageal adenocarcinoma (PANGEA): A phase II precision medicine trial (NCT02213289).

Abstract Poster

Authors

null

Smita Suhas Joshi

University of Chicago, Chicago, IL

Smita Suhas Joshi , Steven Brad Maron , S Lomnicki , Blase N. Polite , Manish Sharma , Jennifer Ibe , Kenisha Allen , Christine Racette , Murtuza M. Rampurwala , Andrea Louise Amico , Ardaman Shergill , Mark Kozloff , Brooke Elizabeth Phillips , Grace K. Suh , Sunil Narula , Shayan Rayani , Kristen Kipping-Johnson , Erin Wojak , Hedy L. Kindler , Daniel V.T. Catenacci

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2018 Gastrointestinal Cancers Symposium

Session Type

Trials in Progress Poster Session

Session Title

Trials in Progress Poster Session A: Cancers of the Esophagus and Stomach

Track

Cancers of the Esophagus and Stomach

Sub Track

Multidisciplinary Treatment

Clinical Trial Registration Number

NCT02213289

Citation

J Clin Oncol 36, 2018 (suppl 4S; abstr TPS198)

DOI

10.1200/JCO.2018.36.4_suppl.TPS198

Abstract #

TPS198

Poster Bd #

M12

Abstract Disclosures

Similar Posters

First Author: Timothy Jay Price

First Author: Kohei Shitara

First Author: Jose Lutzky

First Author: Daniel V.T. Catenacci